PYC Therapeutics Limited (PYC.AX)

AUD 1.41

(-6.0%)

Long Term Debt Summary of PYC Therapeutics Limited

  • PYC Therapeutics Limited's latest annual long term debt in 2024 was - AUD , down 0.0% from previous year.
  • PYC Therapeutics Limited's latest quarterly long term debt in 2024 FY was - AUD , down -100.0% from previous quarter.
  • PYC Therapeutics Limited reported annual long term debt of 137.67 Thousand AUD in 2023, down -79.87% from previous year.
  • PYC Therapeutics Limited reported annual long term debt of 683.96 Thousand AUD in 2022, up 26.0% from previous year.
  • PYC Therapeutics Limited reported quarterly long term debt of - AUD for 2024 Q4, down 0.0% from previous quarter.
  • PYC Therapeutics Limited reported quarterly long term debt of - AUD for 2024 FY, down -100.0% from previous quarter.

Annual Long Term Debt Chart of PYC Therapeutics Limited (2024 - 2005)

Historical Annual Long Term Debt of PYC Therapeutics Limited (2024 - 2005)

Year Long Term Debt Long Term Debt Growth
2024 - AUD 0.0%
2023 137.67 Thousand AUD -79.87%
2022 683.96 Thousand AUD 26.0%
2021 542.82 Thousand AUD -15.86%
2020 645.17 Thousand AUD 0.0%
2019 - AUD 0.0%
2018 - AUD 0.0%
2017 - AUD 0.0%
2016 - AUD 0.0%
2015 - AUD 0.0%
2014 - AUD 0.0%
2013 - AUD 0.0%
2012 - AUD 0.0%
2011 - AUD -100.0%
2010 1.23 Million AUD 20.42%
2009 1.02 Million AUD 0.0%
2008 - AUD 0.0%
2007 - AUD 0.0%
2006 - AUD 0.0%
2005 - AUD 0.0%

Peer Long Term Debt Comparison of PYC Therapeutics Limited

Name Long Term Debt Long Term Debt Difference
EZZ Life Science Holdings Limited - AUD NaN%
Anatara Lifesciences Ltd - AUD NaN%
Zelira Therapeutics Limited 2.11 Million AUD 100.0%
Biome Australia Limited - AUD NaN%
Patrys Limited - AUD NaN%
Orthocell Limited 540.72 Thousand AUD 100.0%
Imugene Limited - AUD NaN%
Noxopharm Limited - AUD NaN%
Chimeric Therapeutics Limited - AUD NaN%
Prescient Therapeutics Limited - AUD NaN%
Proteomics International Laboratories Limited 221.03 Thousand AUD 100.0%
Cynata Therapeutics Limited - AUD NaN%
CSL Limited 14.48 Billion AUD 100.0%
Arovella Therapeutics Limited - AUD NaN%
Bio-Gene Technology Limited - AUD NaN%
Clinuvel Pharmaceuticals Limited 509.92 Thousand AUD 100.0%
Starpharma Holdings Limited 1.95 Million AUD 100.0%
Nanollose Limited - AUD NaN%
Memphasys Limited - AUD NaN%
Invex Therapeutics Ltd - AUD NaN%
NeuroScientific Biopharmaceuticals Limited - AUD NaN%
Amplia Therapeutics Limited 13.89 Thousand AUD 100.0%
Botanix Pharmaceuticals Limited - AUD NaN%
Island Pharmaceuticals Limited - AUD NaN%
Race Oncology Limited - AUD NaN%
Nyrada Inc. - AUD NaN%
Telix Pharmaceuticals Limited 15.88 Million AUD 100.0%
Dimerix Limited 69.51 Thousand AUD 100.0%
PharmAust Limited - AUD NaN%
Immutep Limited 1.04 Million AUD 100.0%
Clarity Pharmaceuticals Ltd - AUD NaN%
Alterity Therapeutics Limited 51.91 Thousand AUD 100.0%
BTC Health Limited - AUD NaN%
Acrux Limited - AUD NaN%
Neuren Pharmaceuticals Limited - AUD NaN%
Biotron Limited - AUD NaN%
Tissue Repair Ltd - AUD NaN%
AdAlta Limited 1.08 Million AUD 100.0%
Radiopharm Theranostics Limited - AUD NaN%
Hexima Limited - AUD NaN%
AnteoTech Limited 19.22 Thousand AUD 100.0%
Paradigm Biopharmaceuticals Limited 117.48 Thousand AUD 100.0%
Recce Pharmaceuticals Ltd 587.1 Thousand AUD 100.0%
Avecho Biotechnology Limited 98.22 Thousand AUD 100.0%
Actinogen Medical Limited - AUD NaN%
Immuron Limited 132.94 Thousand AUD 100.0%
Argenica Therapeutics Limited - AUD NaN%